MAPT and neurodegenerative disease: Disruption of the glymphatic system has been linked to the abnormal buildup of metabolites (Aβ, phosphorylated tau, α-synuclein), which are associated with neurodegenerative diseases such as Alzheimer’s and Parkinson’s diseases [1,28,31,32,34,35].